These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16415486)

  • 1. Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.
    Watala C; Boncler M; Gresner P
    Pharmacol Rep; 2005; 57 Suppl():42-58. PubMed ID: 16415486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.
    Watala C
    Curr Pharm Des; 2005; 11(18):2331-65. PubMed ID: 16022671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy in patients with diabetes mellitus.
    Grove EL; Gregersen S
    Curr Vasc Pharmacol; 2012 Jul; 10(4):494-505. PubMed ID: 22272895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.
    Watala C; Pluta J; Golanski J; Rozalski M; Czyz M; Trojanowski Z; Drzewoski J
    J Mol Med (Berl); 2005 Feb; 83(2):148-58. PubMed ID: 15723265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets, vascular disease, and diabetes mellitus.
    Winocour PD
    Can J Physiol Pharmacol; 1994 Mar; 72(3):295-303. PubMed ID: 8069776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Angiolillo DJ
    Curr Pharm Des; 2012; 18(33):5273-93. PubMed ID: 22724415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
    Santilli F; Lapenna D; La Barba S; Davì G
    Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function profiles in patients with diabetes mellitus.
    Rollini F; Franchi F; Muñiz-Lozano A; Angiolillo DJ
    J Cardiovasc Transl Res; 2013 Jun; 6(3):329-45. PubMed ID: 23404189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy.
    Singla A; Antonino MJ; Bliden KP; Tantry US; Gurbel PA
    Am Heart J; 2009 Nov; 158(5):784.e1-6. PubMed ID: 19853698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of platelets in diabetes-related vascular complications.
    Sobol AB; Watala C
    Diabetes Res Clin Pract; 2000 Sep; 50(1):1-16. PubMed ID: 10936664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
    Natarajan A; Zaman AG; Marshall SM
    Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy.
    Anfossi G; Trovati M
    Cardiovasc Hematol Agents Med Chem; 2006 Apr; 4(2):111-28. PubMed ID: 16611047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
    Angiolillo DJ; Bernardo E; Capodanno D; Vivas D; Sabaté M; Ferreiro JL; Ueno M; Jimenez-Quevedo P; Alfonso F; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2010 Mar; 55(11):1139-46. PubMed ID: 20223369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet in diabetes: focus on prevention of ischemic events.
    Colwell JA; Nesto RW
    Diabetes Care; 2003 Jul; 26(7):2181-8. PubMed ID: 12832332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation re-sequencing of genes involved in increased platelet reactivity in diabetic patients on acetylsalicylic acid.
    Postula M; Janicki PK; Eyileten C; Rosiak M; Kaplon-Cieslicka A; Sugino S; Wilimski R; Kosior DA; Opolski G; Filipiak KJ; Mirowska-Guzel D
    Platelets; 2016 Jun; 27(4):357-64. PubMed ID: 26599574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and diabetes mellitus.
    Santilli F; Simeone P; Liani R; Davì G
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():28-39. PubMed ID: 25986598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of aspirin resistance in patients with type 2 diabetes.
    Fateh-Moghadam S; Plöckinger U; Cabeza N; Htun P; Reuter T; Ersel S; Gawaz M; Dietz R; Bocksch W
    Acta Diabetol; 2005 Jun; 42(2):99-103. PubMed ID: 15944844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.
    Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS
    Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.